The Private Sector Delegation (PSD) has devoted considerable energy over the past six months to examining and discussing the Global Fund’s 2017-2022 Strategy. These discussions spanned five separate in-person events as well as electronic dialogues. The PSD intentionally carved out designated space within the official strategic consultation process to gather broad private sector-specific input. In order to capture the perspectives … Read More
Meet the PSD: Jami Taylor
Jami Taylor Senior Director, Global Access Policy Johnson & Johnson How did you become involved with the Global Fund? My company began its engagement with the Global Fund when we joined the PSD Advisory Group in the summer of 2014. We had been deeply involved in HIV advocacy and product innovation for more than a decade, and had recently entered … Read More
Seeking Private Sector Input into the Global Fund’s Future Strategy: Upcoming Consultations for Business
The PSD is seeking input from a wide range of Global Fund partners and stakeholders from the business sector into on-going dialogues this year aimed at developing the next Global Fund strategy. The new strategy will cover the five-year period from 2017 to 2021 and will serve as an organizational framework outlining the Fund’s core mission, goals and objectives for … Read More
PSD Hosts Event to Highlight Private Sector Role in Strengthening Health Systems
At a recent convening in Geneva, Global Fund Executive Director Mark Dybul drew attention to opportunities for private sector partners to bring core business expertise to strengthening country health systems. The event, hosted by the PSD on the margins of the 33rd Board meeting in late March, focused on the role that strong health systems play in combatting HIV/AIDS, TB … Read More
New Board Leadership, Strategy Discussions Take Center Stage at Global Fund 33rd Board Meeting
The Global Fund’s Board met in Geneva for its 33rd Meeting from March 30-April 1, where questions of new leadership and future strategic direction took center stage. The PSD held its semi-annual pre-Board meeting on March 29 to review and propose positions on the slate of upcoming Board decisions. Representatives from AbbVie, Accenture Development Partnerships, Anglo American, BD, Eli Lilly, … Read More
Business and the Health Millennium Development Goals in India: Closing the Gaps
A new report by GBCHealth, written in partnership with the MDG Health Alliance, presents a snapshot of health-related corporate investments in India, with a focus on business action on the MDGs. Based on survey findings from 23 leading Indian and multinational companies, the report – titled Business and the Health Millennium Development Goals: Closing the Gaps – documents the key … Read More
Looking Back on the 1st Year of the GFATM New Funding Model
In May 2014, countries submitted concept notes in the first review window of the new approach to grant-making approved by the Board for full implementation just two months earlier. By the end of the year, the Technical Review Panel (TRP) had reviewed 111 concept notes, approximately 43% of all expected country submissions for the 2014-2016 allocation period and representing nearly … Read More
New Private Sector Opportunities Approved, Governance Reforms Launched at Global Fund 32nd Board Meeting
November 18 – 21, 2014 | Montreux, Switzerland The Global Fund Board met for its 32nd Board meeting in Montreux, Switzerland from November 18-21. Over the course of the meetings, the Board approved major decisions including: amendments allowing the private sector to make restricted financial contributions against unfunded portions of approved country grant requests reforms to enhance Board and committee … Read More
Recent Events and GF Results Highlight Global Progress Against the Three Diseases
On World AIDS Day, the Global Fund announced key programmatic results from Global Fund-supported grant programs in 2014, showing steady gains across indicators, including a 20% scale-up in people on anti-retroviral therapy, a 24% scale-up in bed net distribution, and a 39% scale up in people treated for multi-drug-resistant TB since 2013. Although the results indicate positive signs of progress, … Read More
Meet the PSD: Luisa Engel and Dr. Gerhard Hesse
Luisa Engel Director of External Relations, (RED) Dr. Gerhard Hesse Head of Global Partnering / Vector Control, Bayer How did (RED) become involved with the Global Fund? The Global Fund is part of (RED)’s DNA. The Fund was established in 2002 but it was struggling to get funding from the corporate sector and because its charter is to be a public-private partnership, it was … Read More